Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
36
NCT02572635
A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVax
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 31, 2015
Completion: Sep 30, 2016